Figures & data
Figure 1. Relative expression levels of KDM6B mRNA levels in NSCLC patients and healthy control. Student’s t test indicated that serum level of KDM6B was significantly decreased in NSCLC patients, compared with healthy control. ***: indicated p < .001.
![Figure 1. Relative expression levels of KDM6B mRNA levels in NSCLC patients and healthy control. Student’s t test indicated that serum level of KDM6B was significantly decreased in NSCLC patients, compared with healthy control. ***: indicated p < .001.](/cms/asset/f8f18e8b-65a3-404a-94f7-2828bd6149e0/ianb_a_1620758_f0001_b.jpg)
Figure 2. The comparison of KDM6B mRNA levels among NSCLC patients based on their age (A), gender (B), clinical stage (C) and lymph node metastasis (D). *p < .05 and **p < .01 indicated the significant difference between the compared two.
![Figure 2. The comparison of KDM6B mRNA levels among NSCLC patients based on their age (A), gender (B), clinical stage (C) and lymph node metastasis (D). *p < .05 and **p < .01 indicated the significant difference between the compared two.](/cms/asset/e0d0f334-3793-4cbf-87e0-e31f0d28006a/ianb_a_1620758_f0002_b.jpg)
Table 1. Association between KDM6B expression and clinicopathological characteristics of NSCLC patients.